Report
Science Corp says it raised $400 million in Series D funding
TechCrunch reports Science aims to bring its PRIMA vision implant to the US through an FDA exemption.
TLDR
A person familiar with the deal told TechCrunch the $400 million round valued Science Corp at $3.5 billion. The outlet reports that its PRIMA implant helps people with age-related macular degeneration recover some vision and is available in Germany. Science aims to use the funding to seek US approval through the FDA’s Humanitarian Device Exemption, according to TechCrunch.
Combined views
8.7K
2 Sources, first seen ago

Comments